Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation for Motor Skill Learning
N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial looks at how brain regions control our sense of limbs and hand movements. It might help us develop better rehab protocols for movement issues.
Who is the study for?
This trial is for right-handed individuals aged 18-45, free of COVID symptoms, without metal implants (except titanium), dreadlocks/weaves/extensions, hand/arm injuries not fully recovered, magnetic/metallic/mechanical implants, claustrophobia issues, IUDs with unknown MR compatibility. Pregnant women or those who might be pregnant are excluded. Participants must avoid excessive alcohol/drugs/caffeine and lack sleep before testing.Check my eligibility
What is being tested?
The study tests how brain regions contribute to proprioception and motor skill learning using Theta burst transcranial magnetic stimulation (TMS) versus a sham procedure. It aims to improve rehabilitation methods for patients with movement deficits by understanding the frontal and parietal brain areas' roles.See study design
What are the potential side effects?
Possible side effects include discomfort from lying still in an MRI scanner for those with higher BMI or claustrophobia; headaches; reactions at the TMS site like scalp discomfort or headache; rare risk of seizure due to TMS; and potential unknown risks of fMRI on unborn children.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Motor skill
Proprioception
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Supramarginal gyrus (SMG)Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over the supramarginal gyrus (SMG).
Group II: Dorsolateral prefrontal cortex (DLPFC)Experimental Treatment1 Intervention
Theta burst transcranial magnetic stimulation (cTBS) will be applied over dorsolateral prefrontal cortex (DLPFC).
Group III: Sham control groupPlacebo Group2 Interventions
Sham theta burst transcranial magnetic stimulation (cTBS) will be applied over the vertex.
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,662 Total Patients Enrolled
3 Trials studying Basic Science
720 Patients Enrolled for Basic Science
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
649,489 Total Patients Enrolled
3 Trials studying Basic Science
720 Patients Enrolled for Basic Science
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have any major visual, hearing, balance issues, or a history of severe neurological conditions.I have vision problems not fixed by glasses or contacts.I do not have severe headaches, glaucoma, heart or lung disease, high blood pressure, psychiatric conditions, or learning/attention issues.I have fully recovered from any serious hand or arm injuries.I am not on medications that affect brain activity or seizure risk.I haven't had any Covid symptoms in the last week.I am between 18 and 45 years old and right-handed.I am not pregnant nor suspect I might be.I was able to perform tasks and follow instructions during the familiarization session.
Research Study Groups:
This trial has the following groups:- Group 1: Supramarginal gyrus (SMG)
- Group 2: Sham control group
- Group 3: Dorsolateral prefrontal cortex (DLPFC)
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the elderly population eligible for this medical research?
"In line with the trial's prerequisites, applicants must be between 18 and 45 years old."
Answered by AI
How many participants are being accepted for this trial?
"Affirmative. Evident on clinicaltrials.gov, this medical exploration was posted in June of 2023 and is still actively searching for participants to recruit from a single site. The goal is to secure 100 individuals that meet the criteria set forth by the study's authors."
Answered by AI
Is the enrollment period for this medical trial still open?
"Affirmative. Clinicaltrials.gov holds evidence that this clinical trial is currently accepting patients, with the initial post having been made on June 9th 2023 and latterly updated on June 30th 2023. This study requires 100 volunteers to be taken in at one site."
Answered by AI
Am I eligible to partake in this scientific investigation?
"This experiment requires 100 volunteers with basic scientific knowledge to be aged 18-45. The most important criteria for admission are that potential participants must have their right hand as a dominant limb, not report any symptoms of Covid in the preceding week, and meet the age restrictions mentioned previously."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger